Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001362310-08-000908
Filing Date
2008-02-14
Accepted
2008-02-14 12:21:42
Documents
1
Group Members
JOHN S. CLARK IIROBERT W. BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A c72466sc13gza.htm SC 13G/A 85456
  Complete submission text file 0001362310-08-000908.txt   87745
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Subject) CIK: 0000812796 (see all company filings)

EIN.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-39976 | Film No.: 08611221
SIC: 2834 Pharmaceutical Preparations

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

EIN.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A